US Stock MarketDetailed Quotes

SQZB SQZ Biotechnologies

Watchlist
  • 0.025
  • 0.0000.00%
15min DelayClose Dec 20 16:00 ET
737.28KMarket Cap-0.01P/E (TTM)

SQZ Biotechnologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
33.58%-14.53M
25.42%-15.27M
-16.34%-23.77M
-1.72%-83.55M
1.24%-20.76M
-4.72%-21.88M
-4.25%-20.48M
0.73%-20.43M
-90.35%-82.14M
-9.26%-21.02M
Net income from continuing operations
-4.40%-23.64M
24.58%-16.77M
15.93%-17.69M
-15.60%-79.46M
-14.59%-13.55M
-0.86%-22.64M
-16.60%-22.24M
-36.62%-21.04M
-36.06%-68.74M
32.83%-11.82M
Operating gains losses
-800.00%-7K
----
----
371.43%33K
---10K
0.00%1K
--1K
--41K
--7K
--0
Depreciation and amortization
-3.05%2.76M
-16.56%2.24M
10.90%3.05M
5.93%11.68M
25.02%3.39M
2.52%2.85M
-1.68%2.69M
-1.75%2.75M
0.80%11.03M
-2.30%2.71M
Change In working capital
86.02%-624K
44.75%-1.79M
-137.72%-9.83M
26.51%-24.21M
13.04%-12.37M
-11.46%-4.46M
37.07%-3.24M
56.77%-4.14M
-352.57%-32.94M
-146.30%-14.22M
-Change in receivables
--0
--0
--0
370.76%3M
--0
--0
--0
58.56%3M
-6,055.56%-1.11M
---3M
-Change in prepaid assets
-21.67%1.08M
204.95%1.6M
90.81%-81K
-181.09%-373K
36.76%-1.4M
-39.55%1.38M
-73.60%525K
45.04%-881K
115.75%460K
17.48%-2.21M
-Change in payables and accrued expense
-35.90%-318K
-165.46%-1.07M
-565.55%-6.74M
383.31%3.82M
27.19%3.43M
-133.33%-234K
404.09%1.64M
51.13%-1.01M
128.61%791K
9.71%2.7M
-Change in other current assets
----
----
----
200.00%323K
----
----
----
----
---323K
----
-Change in other current liabilities
64.23%-887K
10.42%-2.14M
-25.24%-2.97M
-12.44%-9.99M
-34.57%-2.75M
-11.01%-2.48M
-4.78%-2.39M
-1.89%-2.37M
5.82%-8.89M
33.51%-2.04M
-Change in other working capital
84.03%-500K
94.08%-178K
98.71%-37K
12.08%-20.99M
-28.14%-11.98M
34.19%-3.13M
30.26%-3.01M
47.40%-2.87M
-602.80%-23.87M
-275.80%-9.35M
Cash from discontinued investing activities
Operating cash flow
33.58%-14.53M
25.42%-15.27M
-16.34%-23.77M
-1.72%-83.55M
1.24%-20.76M
-4.72%-21.88M
-4.25%-20.48M
0.73%-20.43M
-90.35%-82.14M
-9.26%-21.02M
Investing cash flow
Cash flow from continuing investing activities
113.27%15K
235.00%108K
66.49%-65K
20.39%-488K
-101K
-22.83%-113K
70.80%-80K
21.46%-194K
-101.06%-613K
0
Net PPE purchase and sale
113.27%15K
235.00%108K
66.49%-65K
20.39%-488K
---101K
-22.83%-113K
70.80%-80K
21.46%-194K
47.92%-613K
--0
Cash from discontinued investing activities
Investing cash flow
113.27%15K
235.00%108K
66.49%-65K
20.39%-488K
---101K
-22.83%-113K
70.80%-80K
21.46%-194K
-101.06%-613K
--0
Financing cash flow
Cash flow from continuing financing activities
0
0
0
-92.43%4.23M
18.64%331K
291.81%670K
5,943.40%3.2M
-99.95%29K
-51.98%55.91M
-99.63%279K
Net common stock issuance
--0
----
----
-92.79%4.07M
--305K
--670K
----
----
-25.29%56.4M
--0
Proceeds from stock option exercised by employees
--0
--0
--0
-88.23%166K
-90.68%26K
--0
-83.21%111K
-90.30%29K
224.88%1.41M
-28.46%279K
Net other financing activities
----
----
----
----
----
----
----
----
-8.18%-1.9M
--0
Cash from discontinued financing activities
Financing cash flow
--0
--0
--0
-92.43%4.23M
18.64%331K
291.81%670K
5,943.40%3.2M
-99.95%29K
-51.98%55.91M
-99.63%279K
Net cash flow
Beginning cash position
-74.96%27.02M
-66.32%42.18M
-54.73%66.01M
-15.55%145.82M
-48.04%86.54M
-42.43%107.87M
-39.58%125.22M
-15.55%145.82M
315.31%172.66M
52.30%166.56M
Current changes in cash
31.92%-14.52M
12.63%-15.16M
-15.72%-23.84M
-197.29%-79.8M
1.02%-20.53M
-2.45%-21.32M
12.63%-17.35M
-159.58%-20.6M
-120.48%-26.84M
-132.77%-20.74M
End cash Position
-85.56%12.5M
-74.96%27.02M
-66.32%42.18M
-54.73%66.01M
-54.73%66.01M
-48.04%86.54M
-42.43%107.87M
-39.58%125.22M
-15.55%145.82M
-15.55%145.82M
Free cash flow
33.92%-14.53M
25.49%-15.32M
-15.37%-23.84M
-1.60%-84.07M
0.76%-20.86M
-4.80%-21.99M
-3.22%-20.56M
0.81%-20.66M
-86.68%-82.75M
-8.56%-21.02M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 33.58%-14.53M25.42%-15.27M-16.34%-23.77M-1.72%-83.55M1.24%-20.76M-4.72%-21.88M-4.25%-20.48M0.73%-20.43M-90.35%-82.14M-9.26%-21.02M
Net income from continuing operations -4.40%-23.64M24.58%-16.77M15.93%-17.69M-15.60%-79.46M-14.59%-13.55M-0.86%-22.64M-16.60%-22.24M-36.62%-21.04M-36.06%-68.74M32.83%-11.82M
Operating gains losses -800.00%-7K--------371.43%33K---10K0.00%1K--1K--41K--7K--0
Depreciation and amortization -3.05%2.76M-16.56%2.24M10.90%3.05M5.93%11.68M25.02%3.39M2.52%2.85M-1.68%2.69M-1.75%2.75M0.80%11.03M-2.30%2.71M
Change In working capital 86.02%-624K44.75%-1.79M-137.72%-9.83M26.51%-24.21M13.04%-12.37M-11.46%-4.46M37.07%-3.24M56.77%-4.14M-352.57%-32.94M-146.30%-14.22M
-Change in receivables --0--0--0370.76%3M--0--0--058.56%3M-6,055.56%-1.11M---3M
-Change in prepaid assets -21.67%1.08M204.95%1.6M90.81%-81K-181.09%-373K36.76%-1.4M-39.55%1.38M-73.60%525K45.04%-881K115.75%460K17.48%-2.21M
-Change in payables and accrued expense -35.90%-318K-165.46%-1.07M-565.55%-6.74M383.31%3.82M27.19%3.43M-133.33%-234K404.09%1.64M51.13%-1.01M128.61%791K9.71%2.7M
-Change in other current assets ------------200.00%323K-------------------323K----
-Change in other current liabilities 64.23%-887K10.42%-2.14M-25.24%-2.97M-12.44%-9.99M-34.57%-2.75M-11.01%-2.48M-4.78%-2.39M-1.89%-2.37M5.82%-8.89M33.51%-2.04M
-Change in other working capital 84.03%-500K94.08%-178K98.71%-37K12.08%-20.99M-28.14%-11.98M34.19%-3.13M30.26%-3.01M47.40%-2.87M-602.80%-23.87M-275.80%-9.35M
Cash from discontinued investing activities
Operating cash flow 33.58%-14.53M25.42%-15.27M-16.34%-23.77M-1.72%-83.55M1.24%-20.76M-4.72%-21.88M-4.25%-20.48M0.73%-20.43M-90.35%-82.14M-9.26%-21.02M
Investing cash flow
Cash flow from continuing investing activities 113.27%15K235.00%108K66.49%-65K20.39%-488K-101K-22.83%-113K70.80%-80K21.46%-194K-101.06%-613K0
Net PPE purchase and sale 113.27%15K235.00%108K66.49%-65K20.39%-488K---101K-22.83%-113K70.80%-80K21.46%-194K47.92%-613K--0
Cash from discontinued investing activities
Investing cash flow 113.27%15K235.00%108K66.49%-65K20.39%-488K---101K-22.83%-113K70.80%-80K21.46%-194K-101.06%-613K--0
Financing cash flow
Cash flow from continuing financing activities 000-92.43%4.23M18.64%331K291.81%670K5,943.40%3.2M-99.95%29K-51.98%55.91M-99.63%279K
Net common stock issuance --0---------92.79%4.07M--305K--670K---------25.29%56.4M--0
Proceeds from stock option exercised by employees --0--0--0-88.23%166K-90.68%26K--0-83.21%111K-90.30%29K224.88%1.41M-28.46%279K
Net other financing activities ---------------------------------8.18%-1.9M--0
Cash from discontinued financing activities
Financing cash flow --0--0--0-92.43%4.23M18.64%331K291.81%670K5,943.40%3.2M-99.95%29K-51.98%55.91M-99.63%279K
Net cash flow
Beginning cash position -74.96%27.02M-66.32%42.18M-54.73%66.01M-15.55%145.82M-48.04%86.54M-42.43%107.87M-39.58%125.22M-15.55%145.82M315.31%172.66M52.30%166.56M
Current changes in cash 31.92%-14.52M12.63%-15.16M-15.72%-23.84M-197.29%-79.8M1.02%-20.53M-2.45%-21.32M12.63%-17.35M-159.58%-20.6M-120.48%-26.84M-132.77%-20.74M
End cash Position -85.56%12.5M-74.96%27.02M-66.32%42.18M-54.73%66.01M-54.73%66.01M-48.04%86.54M-42.43%107.87M-39.58%125.22M-15.55%145.82M-15.55%145.82M
Free cash flow 33.92%-14.53M25.49%-15.32M-15.37%-23.84M-1.60%-84.07M0.76%-20.86M-4.80%-21.99M-3.22%-20.56M0.81%-20.66M-86.68%-82.75M-8.56%-21.02M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data